Profil
Jeff Macdonald is currently Executive Director-Investor Relations at Jazz Pharmaceuticals Plc and will hold the same title at Vaxcyte, Inc. starting in 2025.
Former roles include Senior Director-Corporate Communications at Acorda Therapeutics, Inc. and Senior Director-Investor Relations at G1 Therapeutics, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Washington & Lee University.
Postes actifs de Jeff Macdonald
| Sociétés | Poste | Début |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Investor Relations Contact | - |
| VAXCYTE, INC. | Investor Relations Contact | 01/06/2025 |
Anciens postes connus de Jeff Macdonald
| Sociétés | Poste | Fin |
|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Contact | 04/01/2021 |
| ACORDA THERAPEUTICS, INC. | Investor Relations Contact | 10/05/2012 |
Formation de Jeff Macdonald
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
















